New Delhi:A plea has been moved in the Supreme Court seeking directions to constitute a medical experts’ panel of experts’ from the All India Institute of Medical Science, Delhi, headed by its director and supervised by a former judge of the apex court to examine the Covishield vaccine side effects and its risk factors.
The plea by advocate Vishal Tiwari said recently it is revealed that Covishield vaccine had caused and may cause side effects in rare cases and its developer AstraZeneca has said that its AZD1222 vaccine against Covid-19, which was made under licence in India as Covishield, could cause low platelet counts and formation of blood clots in “very rare” cases.
“AstraZeneca has accepted a link between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS), a medical condition characterised by abnormally low levels of platelets and the formation of blood clots. AstraZeneca’s vaccine formula was licensed to Pune-based vaccine maker Serum Institute of India (SII) during the coronavirus pandemic for the manufacture of Covishield. More than 175 crore doses of Covishield have been administered in India”, said the plea.